Advancements in Treatment Strategies for Chronic Mesenteric Ischemia: A Comprehensive Review.

Author: CarrafielloGianpaolo, Del GrandeFilippo, FaerberPierre, IerardiAnna Maria, InzerilloAgostino, RicoeurAlexis, SciacquaLucilla Violetta, VanzulliAndrea, XhepaGenti

Paper Details 
Original Abstract of the Article :
Chronic mesenteric ischemia (CMI) arises from the inability to achieve adequate intestinal blood flow after meals, leading to an imbalance between oxygen and metabolite supply and demand. The true incidence of CMI remains uncertain. However, the occurrence of mesenteric artery occlusive disease (MAO...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10672107/

データ提供:米国国立医学図書館(NLM)

Chronic Mesenteric Ischemia: A Comprehensive Review of Treatment Strategies

Chronic mesenteric ischemia (CMI), a condition characterized by inadequate blood flow to the intestines, can lead to significant abdominal pain and discomfort. This research provides a comprehensive review of treatment strategies for CMI, highlighting the evolution of approaches from surgical interventions to endovascular revascularization.

Exploring Treatment Options for Chronic Mesenteric Ischemia

The review examines the historical development of CMI treatment, starting with surgical procedures and progressing to endovascular revascularization methods such as percutaneous transluminal angioplasty (PTA) and primary stenting (PMAS). Researchers aim to provide clinicians with a comprehensive overview of the available treatment options and guide their decision-making process.

Endovascular Revascularization: A Promising Approach for CMI

The review concludes that endovascular revascularization, particularly PMAS, is generally favored over PTA alone for the treatment of atherosclerotic mesenteric artery stenosis. However, the authors emphasize the need for further research to compare different stent types and evaluate long-term outcomes.

Dr.Camel's Conclusion

Navigating the complexities of CMI is like traversing a desert landscape with hidden obstacles. This review provides a roadmap for clinicians, outlining the evolution of treatment strategies and highlighting the promise of endovascular revascularization. While endovascular procedures offer significant advantages, further research is essential to optimize treatment outcomes and ensure the best possible care for patients with CMI.

Date :
  1. Date Completed n.d.
  2. Date Revised 2023-11-27
Further Info :

Pubmed ID

38002726

DOI: Digital Object Identifier

PMC10672107

Related Literature

Article Analysis
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.